succinylacetone has been researched along with Genetic Predisposition in 1 studies
succinylacetone: inhibitor of heme biosynthesis
4,6-dioxoheptanoic acid : A dioxo monocarboxylic acid that is heptanoic acid in which oxo groups replace the hydrogens at positions 4 and 6. It is an abnormal metabolite of the tyrosine metabolic pathway and a marker for type 1 tyrosinaemia.
| Excerpt | Relevance | Reference |
|---|---|---|
| " During her pregnancy she was treated with diet (prescribed tyrosine intake 300 mg/day), and nitisinone (60 mg/day)." | 3.76 | Maternal and fetal tyrosinemia type I. ( Benoist, JF; Davit-Spraul, A; Garcia Segarra, N; Grenèche, MO; Imbard, A; Ogier de Baulny, H; Roche, S, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Garcia Segarra, N | 1 |
| Roche, S | 1 |
| Imbard, A | 1 |
| Benoist, JF | 1 |
| Grenèche, MO | 1 |
| Davit-Spraul, A | 1 |
| Ogier de Baulny, H | 1 |
1 other study available for succinylacetone and Genetic Predisposition
| Article | Year |
|---|---|
Maternal and fetal tyrosinemia type I.
Topics: Biomarkers; Child Development; Consanguinity; Cyclohexanones; Diet, Protein-Restricted; DNA Mutation | 2010 |